Dr. Michael T. Giordano, MD

Dr. Giordano practices at Baltimore- Harford Surgical Centers in Bel Air, Maryland.

Dr. Giordano's NPI, 1154438349, was assigned on August 24, 2006. Dr. Giordano graduated from Eastern Virginia Medical School in 2004. Dr. Giordano holds Maryland license D65991.

Dr. Giordano's primary practice is Baltimore- Harford Surgical Centers, at 615 W Macphail Rd, Bel Air, MD 21014 in Harford County. The practice phone is (443) 643-9900.

Dr. Giordano's primary practice is Baltimore- Harford Surgical Centers in Bel Air, Maryland. Dr. Giordano is also affiliated with University of Maryland Upper Chesapeake Medical Center Bel Air. The medical group on file is Emergency Medicine Physicians (EMP). Dmand AI also links Dr. Giordano to 4 more medical groups, 3 group practices and clinics and 3 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Giordano practices, 7 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Giordano's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Giordano's licenses on file in 2 states: Maryland and Delaware.

CMS data shows 3,217 Medicare services from Dr. Giordano across 20 procedure codes in 2024, for 558 Medicare patients. Medicare paid $143,363 for them. Every service was in an office.

CMS counts 558 Medicare patients who saw Dr. Giordano in 2024. The largest group is 65 to 74, with 281 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 0.87, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Giordano's median patient age at 73, with 43% women.

In 2024, Dr. Giordano wrote 5,849 Medicare Part D claims for 604 patients. 93% of them were for generic drugs. CMS names the drug for 5,271 of them, across 84 drugs with 11 or more claims each, at $222,835 in total drug cost. In 2023, CMS named 4,356 claims across 73 drugs.

Dr. Giordano accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Giordano as offering telehealth.

CMS Open Payments shows 111 general payments to Dr. Giordano from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $552.

Dr. Giordano graduated from Eastern Virginia Medical School in 2004.